Radioimmunoscintigraphy of intracranial glioma xenograft with a technetium-99m-labeled mouse monoclonal antibody specifically recognizing type III mutant epidermal growth factor receptor

scientific article published in July 2003

Radioimmunoscintigraphy of intracranial glioma xenograft with a technetium-99m-labeled mouse monoclonal antibody specifically recognizing type III mutant epidermal growth factor receptor is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1049970223
P356DOI10.1023/A:1024320516341
P698PubMed publication ID12892230

P2093author name stringKenta Okamoto
Takeshi Hayashi
Ryuzo Ueda
Tetsuya Higuchi
Hideki Muramatsu
Masaaki Mizuno
Kazuhiro Yoshikawa
Keigo Endo
Toshitada Takahashi
Noboru Oriuchi
Toshihiko Wakabayashi
Norimoto Nakahara
Shinsuke Saga
Jun Yoshida
Osamu Miyaishi
Kenichi Kozaki
Sho Okamoto
Syuntaro Takasu
Norihisa Nakayashiki
P2860cites workLevels of TGF-α and EGFR Protein in Head and Neck Squamous Cell Carcinoma and Patient SurvivalQ27851502
Monoclonal antibody therapy of human gliomas: current status and future approachesQ30879745
Evidence of high incidence of EGFRvIII expression and coexpression with EGFR in human invasive breast cancer by laser capture microdissection and immunohistochemical analysisQ31045910
Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastomaQ33610591
Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastomasQ33881165
A deletion mutation within the ligand binding domain is responsible for activation of epidermal growth factor receptor gene in human brain tumorsQ33937136
EGFRvIII as a promising target for antibody-based brain tumor therapyQ34157678
Reduction-mediated technetium-99m labeling of monoclonal antibodiesQ34328372
A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicityQ35660849
Drug resistance of human glioblastoma cells conferred by a tumor-specific mutant epidermal growth factor receptor through modulation of Bcl-X L and caspase-3-like proteasesQ36097402
Monoclonal antibody against the fusion junction of a deletion-mutant epidermal growth factor receptorQ36135157
Structural alterations of the epidermal growth factor receptor gene in human gliomasQ36930689
Prognostic value of tumour associated antigen immunoreactivity and apoptosis in cerebral glioblastomas: an analysis of 168 casesQ37228212
Impact of the high tyrosine fraction in complementarity determining regions: measured and predicted effects of radioiodination on IgG immunoreactivityQ40416428
Monoclonal antibody 806 inhibits the growth of tumor xenografts expressing either the de2-7 or amplified epidermal growth factor receptor (EGFR) but not wild-type EGFR.Q40792458
Specific targeting of a mutant, activated egf receptor found in glioblastoma using a monoclonal antibodyQ41270902
Monoclonal antibodies to growth factors and growth factor receptors: their diagnostic and therapeutic potential in brain tumorsQ41687861
Evidence for the differential expression of a variant EGF receptor protein in human prostate cancerQ41908287
Production of a single-chain variable fragment antibody recognizing type III mutant epidermal growth factor receptorQ42834600
A new antibody recognizing the vIII mutation of human epidermal growth factor receptorQ44029010
Expression of activated epidermal growth factor receptors, Ras-guanosine triphosphate, and mitogen-activated protein kinase in human glioblastoma multiforme specimensQ44811732
Iodine125 labeled anti-epidermal growth factor receptor-425 in the treatment of malignant astrocytomas. A pilot studyQ45202916
Growth suppression of intracranial xenografted glioblastomas overexpressing mutant epidermal growth factor receptors by systemic administration of monoclonal antibody (mAb) 806, a novel monoclonal antibody directed to the receptor.Q45943467
Amplification and expression of the epidermal growth factor receptor gene in human glioma xenografts.Q48088104
Novel monoclonal antibody specific for the de2-7 epidermal growth factor receptor (EGFR) that also recognizes the EGFR expressed in cells containing amplification of the EGFR geneQ48647863
Phase II trial of murine (131)I-labeled antitenascin monoclonal antibody 81C6 administered into surgically created resection cavities of patients with newly diagnosed malignant gliomasQ48674565
A modeling analysis of monoclonal antibody percolation through tumors: a binding-site barrierQ52479098
The class III variant of the epidermal growth factor receptor (EGFRvIII): characterization and utilization as an immunotherapeutic targetQ55477802
Cell surface localization and density of the tumor-associated variant of the epidermal growth factor receptor, EGFRvIIIQ55478203
Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomasQ55480632
Immunodiagnosis of tumors in vivo using radiolabeled monoclonal antibody A2B5Q70150097
Technetium-99m labeling of murine monoclonal antibody fragmentsQ70290099
Expression of mutated epidermal growth factor receptor by non-small cell lung carcinomasQ70463968
Scintigraphic detection of xenografted renal tumor by anti-renal cancer monoclonal antibody radiolabeled with technetium-99mQ71773924
Frequent expression of a mutant epidermal growth factor receptor in multiple human tumorsQ71805186
High affinity restricts the localization and tumor penetration of single-chain fv antibody moleculesQ74020325
P433issue3
P921main subjectxenograftQ64148587
P304page(s)247-256
P577publication date2003-07-01
P1433published inJournal of Neuro-OncologyQ15752119
P1476titleRadioimmunoscintigraphy of intracranial glioma xenograft with a technetium-99m-labeled mouse monoclonal antibody specifically recognizing type III mutant epidermal growth factor receptor
P478volume63

Reverse relations

cites work (P2860)
Q36764016Emerging monoclonal antibody therapies for malignant gliomas
Q34105339Epidermal Growth Factor Receptor in Glioma: Signal Transduction, Neuropathology, Imaging, and Radioresistance
Q36217582HER1/EGFR tyrosine kinase inhibitors for the treatment of glioblastoma multiforme
Q39389369Harnessing Integrative Omics to Facilitate Molecular Imaging of the Human Epidermal Growth Factor Receptor Family for Precision Medicine.
Q34787997Immunoimaging of CXCR4 expression in brain tumor xenografts using SPECT/CT
Q39144294MR signal amplification for imaging of the mutant EGF receptor in orthotopic human glioma model.
Q84634867Macrophage migration inhibitory factor plays a pivotal role in hepatocellular carcinoma and may be a noninvasive imaging target
Q36752665Molecular imaging as a tool for personalized and targeted anticancer therapy
Q36936796Multimodality imaging of the HER-kinase axis in cancer
Q36742911Protein-based tumor molecular imaging probes
Q27015045The epidermal growth factor receptor variant III (EGFRvIII): where wild things are altered

Search more.